Literature DB >> 2298858

Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay.

A K Taylor1, S Linkhart, S Mohan, R A Christenson, F R Singer, D J Baylink.   

Abstract

Reliable markers of bone formation are essential to the investigation of metabolic bone disorders. In this regard, evidence indicates that circulating levels of human osteocalcin (OC) correlate with the skeletal isoenzyme of alkaline phosphatase and can be used as an index of bone formation. A disadvantage of using serum OC as a marker of formation is its diurnal variation. To address this problem we carried out our studies to determine the usefulness of urine in the assessment of bone turnover. Using a midmolecule specific human OC RIA, we were able to detect OC in urine of normal adults (42 mugeq/g creatinine), normal children (849 mu/geq/g creatinine), and Paget's disease patients (613 mugeq/g creatinine). Immunoreactive fragments of OC in human urine and human serum were separated by high pressure liquid chromatography. Multiple fragments were found in normal adult urine that were not detected in normal adult serum. Uremic and Paget's disease sera contain several immunoreactive forms of OC, other than the intact molecule, not found in normal adult serum. Additionally, both Paget's disease sera and urine contained a specific peak of immunoreactive material, eluting at 25% acetonitrile, that was not found in any other serum or urine tested. Urinary OC (uOC) correlated with both skeletal alkaline phosphatase (r = 0.91) and serum OC (r = 0.83), indices of skeletal formation. While uOC has a diurnal variation similar to that of serum OC, determinations of 24-h uOC give integrated values of daily bone turnover rates. Z-Score analysis indicates that uOC (z = 14.04) is better able to distinguish between normal children with high bone turnover and normal adults than either skeletal alkaline phosphatase (z = 8.87) or serum OC (z = 9.01).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298858     DOI: 10.1210/jcem-70-2-467

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

2.  Serum osteocalcin in metabolic bone diseases: what is its real significance?

Authors:  S Minisola; V Carnevale; M T Pacitti; E Romagnoli; L Scarnecchia; R Rosso; G Minisola; G F Mazzuoli
Journal:  J Endocrinol Invest       Date:  1993-04       Impact factor: 4.256

Review 3.  The role of osteocalcin in human glucose metabolism: marker or mediator?

Authors:  Sarah L Booth; Amanda Centi; Steven R Smith; Caren Gundberg
Journal:  Nat Rev Endocrinol       Date:  2012-11-13       Impact factor: 43.330

Review 4.  New developments in biochemical markers for osteoporosis.

Authors:  P Garnero; P D Delmas
Journal:  Calcif Tissue Int       Date:  1996       Impact factor: 4.333

Review 5.  Vitamin K-dependent carboxylation of osteocalcin: friend or foe?

Authors:  Caren M Gundberg; Jane B Lian; Sarah L Booth
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 6.  Bone turnover markers: understanding their value in clinical trials and clinical practice.

Authors:  R Civitelli; R Armamento-Villareal; N Napoli
Journal:  Osteoporos Int       Date:  2009-02-04       Impact factor: 4.507

7.  Comparison of Bone Turnover Biomarkers in Serum and Urine Measured on an Automated Analytical Platform.

Authors:  Brittany M Wilson; Ryan D Ross; Joshua J Jacobs; Dale Rick Sumner
Journal:  J Appl Lab Med       Date:  2021-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.